A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
- PMID: 26425694
- PMCID: PMC4563128
- DOI: 10.1016/j.ebiom.2015.06.019
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
Abstract
Background: Quantifying latently infected cells is critical to evaluate the efficacy of therapeutic strategies aimed at reducing the size of the long-lived viral reservoir, but the low frequency of these cells makes this very challenging.
Methods: We developed TILDA (Tat/rev Induced Limiting Dilution Assay) to measure the frequency of cells with inducible multiply-spliced HIV RNA, as these transcripts are usually absent in latently infected cells but induced upon viral reactivation. TILDA requires less than a million cells, does not require RNA extraction and can be completed in two days.
Findings: In suppressed individuals on ART, we found the median frequency of latently infected CD4 + T cells as estimated by TILDA to be 24 cells/million, which was 48 times more than the frequency measured by the quantitative viral outgrowth assay, and 6-27 times less than the frequencies of cells harbouring viral DNA measured by PCR-based assays. TILDA measurements strongly correlated with most HIV DNA assays. The size of the latent reservoir measured by TILDA was lower in subjects who initiated ART during the early compared to late stage of infection (p = 0.011). In untreated HIV disease, the frequency of CD4 + cells carrying latent but inducible HIV largely exceeded the frequency of actively producing cells, demonstrating that the majority of infected cells are transcriptionally silent even in the absence of ART.
Interpretations: Our results suggest that TILDA is a reproducible and sensitive approach to measure the frequency of productively and latently infected cells in clinical settings. We demonstrate that the latent reservoir represents a substantial fraction of all infected cells prior to ART initiation.
Research in context: In this manuscript, we describe the development of a novel assay that measures the magnitude of the latent HIV reservoir, the main barrier to HIV eradication. This novel assay, termed TILDA for Tat/rev Induced Limiting Dilution Assay, requires only 10 ml of blood, does not necessitate extraction of viral nucleic acids, is highly reproducible, covers a wide dynamic range of reservoir sizes and can be completed in two days. As such, TILDA may represent an alternative to existing assays used to evaluate the efficacy of therapeutic strategies aimed at reducing the size of the latent HIV reservoir.
Keywords: Eradication; HIV; Inducible virus; Latency; Multiply spliced RNA; Reservoir; TILDA.
Figures
Similar articles
-
TILDA: Tat/Rev Induced Limiting Dilution Assay.Methods Mol Biol. 2022;2407:365-372. doi: 10.1007/978-1-0716-1871-4_24. Methods Mol Biol. 2022. PMID: 34985676
-
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.Viruses. 2020 Sep 2;12(9):973. doi: 10.3390/v12090973. Viruses. 2020. PMID: 32887284 Free PMC article.
-
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1.J Virol Methods. 2020 Feb;276:113778. doi: 10.1016/j.jviromet.2019.113778. Epub 2019 Nov 19. J Virol Methods. 2020. PMID: 31756409
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.Retrovirology. 2018 Jan 17;15(1):9. doi: 10.1186/s12977-017-0385-y. Retrovirology. 2018. PMID: 29343255 Free PMC article. Review.
Cited by
-
Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells.Cells. 2020 Sep 11;9(9):2076. doi: 10.3390/cells9092076. Cells. 2020. PMID: 32932813 Free PMC article.
-
Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription.PLoS Pathog. 2020 Sep 17;16(9):e1008821. doi: 10.1371/journal.ppat.1008821. eCollection 2020 Sep. PLoS Pathog. 2020. PMID: 32941545 Free PMC article.
-
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?Viruses. 2024 Feb 1;16(2):229. doi: 10.3390/v16020229. Viruses. 2024. PMID: 38400005 Free PMC article. Review.
-
International AIDS Society global scientific strategy: towards an HIV cure 2016.Nat Med. 2016 Aug;22(8):839-50. doi: 10.1038/nm.4108. Epub 2016 Jul 11. Nat Med. 2016. PMID: 27400264 Free PMC article.
-
Larvicidal activity and Histopathological changes of Cinnamomum burmannii, Syzygium aromaticum extracts and their combination on Culex pipiens.Saudi J Biol Sci. 2022 Apr;29(4):2591-2596. doi: 10.1016/j.sjbs.2021.12.035. Epub 2021 Dec 17. Saudi J Biol Sci. 2022. PMID: 35531167 Free PMC article.
References
-
- Boulassel M.R., Chomont N., Pai N.P., Gilmore N., Sekaly R.P., Routy J.P. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J. Clin. Virol. 2012;53(1):29–32. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials